Medical oncologist Clifford Hudis discussed the latest research on the link between obesity and cancer, and dietitian Cara Anselmo discussed ways to maintain a healthy weight during and after cancer treatment, for WABC-TV’s annual breast cancer special.
Researchers led by chemist Samuel Danishefsky reported that erythropoietin (also known as EPO), the hormone that controls the production of red blood cells, had been synthesized for the first time.
Surgical oncologist Deborah Capko was one of several experts consulted to rank the greatest risk factors for cancer. Topping the list were smoking, age, and UV radiation from the sun.
Medical oncologist Larry Norton was interviewed about a study from The Cancer Genome Atlas (TCGA), a multicenter collaboration that seeks to understand the molecular changes that characterize cancer. The study found genetic similarities between a subtype of breast cancer and ovarian cancer, suggesting that approved drugs for ovarian cancer may also work in this subtype of breast cancer.
Medical oncologist Clifford Hudis commented on M. D. Anderson Cancer Center’s Moon Shots program, an ambitious initiative aimed at reducing cancer deaths over the next decade.
Medical oncologist Paul Paik commented on a study from The Cancer Genome Atlas (TCGA), a multicenter collaboration that seeks to understand the molecular changes that characterize cancer. The study identified genetic alterations in hundreds of lung tumors, which can help doctors match patients with existing targeted drugs.
Clinical psychologist Allison Applebaum commented on a therapy program focused on improving quality of life for people being treated for advanced cancer.
Infectious disease specialist Kent Sepkowitz was interviewed about necrotizing fasciitis, a rare infection commonly referred to as a flesh-eating bacteria.
Medical oncologist Andrew Seidman commented on a study presented at the American Society of Clinical Oncology’sBreast Cancer Symposium that found that bone scans, liver ultrasounds, and chest x-rays may not have a significant role to play in staging breast cancer.
Medical oncologist Jedd Wolchok spoke about immunotherapy and the drug ipilimumab (Yervoy™), which accelerates the body’s own immune system to fight cancer.
